Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote-ER for Bipolar Depression
NCT00226343Phase 4Completed
- Sponsor
- Cambridge Health Alliance
- Start
- Aug 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD) comparing Depakote-ER with Placebo (2 arms). Primary endpoint: Anxiety and Depressive Symptom severity at 6 weeks. Started Aug 2003; status: completed.
02
Drugs
divalproex sodium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00226343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226343.